https://www.selleckchem.com/pr....oducts/tegatrabetan.
Upon near-infrared irradiation, mitochondria-targeted chemophotothermal synergistic therapy can be realized, further overcoming cisplatin resistance and even eliminating A549R tumors completely. Moreover, such novel Pt(IV)-NPs integrate multimodal targeting (cancer and mitochondria targeting), imaging (near-infrared imaging and photoacoustic imaging), and therapeutic (chemo- and photothermal therapy) moieties in a constant ratio (111) into a single, reproducible, and structurally homogeneous entity, avoiding nonuniform drug loading
Like
Comment
Share
